Breaking News
Solid Biosciences Inc Receives Orphan Drug Designation for Groundbreaking Gene Therapy to Combat Duchenne Muscular Dystrophy
On January 16, 2024, Solid Biosciences Inc. received an orphan drug designation (ODD) from the U.S. Food and Drug Administration...
Instil Bios ITIL306 Program Advancements and Future Possibilities in Cancer Treatment
Instil Bio, Inc. (NASDAQ:TIL) has recently shared an exciting update on its groundbreaking ITIL-306 program, which is currently in Phase...
Momentus Announces 4M Registered Direct Offering with Warrant Option
On January 16, 2024, the search yielded no relevant information regarding the Momentus Announces $4M Registered Direct Offering. However, drawing...
Revolutionizing the Feminine Care Industry Compass Diversified and The Honey Pot Companys 380 Million Collaboration
Compass Diversified (NYSE:CODI) has recently unveiled an exciting collaboration with The Honey Pot Company, LLC, marking a significant milestone in...
Analysts Provide Mixed Ratings and Price Targets for Dutch Bros Inc NYSEBROS
As of January 16, 2024, analysts have set an average 12-month price target of $35.38 for Dutch Bros Inc. (NYSE:BROS),...
Analyst Ratings and Price Targets for Driven Brands Holdings
As of January 16, 2024, the analyst ratings for Driven Brands Holdings (NASDAQ: DRVN) present a diverse range of opinions....
Clear Secure Receives Moderate Buy Consensus with Varying Price Targets
As of January 16, 2024, analysts have given Clear Secure (NYSE: YOU) a moderate buy consensus, with various price targets....
Blackstone Expands Private Equity Business in Singapore to Capitalize on Southeast Asian Opportunities
Blackstone, the world's leading alternative asset manager, has set its sights on expanding its private equity (PE) business in Singapore....
Analyst Raises Price Target for Revolution Medicines Remains Bullish
As of January 16, 2024, Raymond James analyst Laura Prendergast remains bullish on Revolution Medicines (NASDAQ:RVMD), maintaining an "Outperform" rating....
Accelerate Diagnostics Inc Announces Proposed Underwritten Public Offering to Expand Shareholder Base and Fuel Future Growth
On January 16, 2024, Accelerate Diagnostics, Inc. made an exciting announcement of their proposed underwritten public offering. They plan to...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Walgreens Implements Deep Restructuring Following Private Buyout
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
